Retreatment with pegylated interferon plus ribavirin of chronichepatitis C non-responders to interferon plus ribavirin: A meta-analysis.

Risultato della ricerca: Articlepeer review

27 Citazioni (Scopus)

Abstract

BACKGROUND/AIMS: Efficacy of retreatment with pegylated interferon (PEG-IFN) plus ribavirin of non-responders to standard or pegylated IFN plus ribavirin has been assessed in various studies, but sustained virologic response (SVR) rates are variable and factors influencing efficacy and tolerability still remain incompletely defined. We aimed to focus on SVR rates and to identify factors influencing them in this meta-analysis. METHODS: MEDLINE as well as a manual search were used. Studies were included if they were controlled or uncontrolled trials, if they had been published as full-length papers and if they included non-responders to standard or pegylated IFN and ribavirin therapy. Fourteen trials were included in the meta-analysis. Data on study populations, interventions, and outcomes were extracted from trials using a random-effects model. Primary outcome was the SVR rate. RESULTS: The pooled estimate of SVR rate was 16.3% (95% Confidence Interval - 95% CI, 8.3-29.6%). There was a significant heterogeneity among studies (p<0.0001). Heterogeneity was less apparent in studies that included fewer patients with cirrhosis or overweight. By meta-regression, higher SVR rate was observed in trials with a lower prevalence of subjects with genotype 1 infection and with fewer overweight patients. The use of a 24-week retreatment stopping rule did not affect SVR rate. CONCLUSIONS: The overall modest efficacy argues against an indiscriminate retreatment with PEG-IFN and ribavirin of all non-responders. Restricting retreatment to non-overweight patients or to those with genotype 2 or 3 infection, using a 24-week retreatment stopping rule, would optimize the potential benefit with a scarce likelihood of missing a curative response.
Lingua originaleEnglish
Numero di pagine7
RivistaJournal of Hepatology
Volume2009-07
Stato di pubblicazionePublished - 2009

All Science Journal Classification (ASJC) codes

  • Hepatology

Fingerprint Entra nei temi di ricerca di 'Retreatment with pegylated interferon plus ribavirin of chronichepatitis C non-responders to interferon plus ribavirin: A meta-analysis.'. Insieme formano una fingerprint unica.

Cita questo